| Literature DB >> 35783315 |
Nasser M Al-Daghri1, Kaiser Wani1, Malak N K Khattak1, Abdullah M Alnaami1, Osama E Amer1, Naji J Aljohani2, Abdulaziz Hameidi3, Hanan Alfawaz4, Mohammed Alharbi5, Shaun Sabico1.
Abstract
Background: Childhood obesity and pediatric metabolic syndrome (MetS) have steadily increased during the last decade in Saudi Arabia. Intervention programs to prevent cardiometabolic disorders in Arab youth are needed. Objective: In this multi-school intervention study which was disrupted by COVID-19-imposed lockdowns (September 2019-April 2021), a 12-month lifestyle education program focused on improving the cardiometabolic status of Arab adolescents was investigated.Entities:
Keywords: COVID-19 lockdown; adolescents; lifestyle education; metabolic syndrome; school
Year: 2022 PMID: 35783315 PMCID: PMC9245569 DOI: 10.3389/fped.2022.887138
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.569
FIGURE 1Time series graph depicting the recruitment of participants and the educational sessions provided during the study period. In panel (A), the number of participants recruited per session at the respective schools and their follow-up through virtual meeting platforms during the emergency of COVID-19 is depicted while panels (B) and (C) depict the blood samples collected at recruitment and end of study, respectively.
Pediatric definition of MetS.
| MetS components | Cutoff | Boys | Girls | ||||||||||
| 12 | 13 | 14 | 15 | 16 | > 16 | 12 | 13 | 14 | 15 | 16 | > 16 | ||
| Central Obesity | WC (cm) ≥ 90th percentile | 90 | 95.5 | 97 | 101.6 | 101.6 | 101.6 | 82 | 86 | 88 | 88.9 | 88.9 | 88.9 |
| Hypertension | SBP (mmHg) ≥ 90th Percentile | 126 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 |
| DBP (mmHg) ≥ 90th Percentile | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | |
| Hypertriglyceridemia | TG ≥ 110 mg/dl or 1.24 mmol/L for 15 years below; TG ≥ 150 mg/dl or 1.7 mmol/L for 16 and above | ||||||||||||
| Low HDL-Cholesterol | HDL ≤ 40 mg/dl or 1.03 mmol/L | ||||||||||||
| Hyperglycemia | FBG ≥ 110 mg/dl or 6.1 mmol/L | ||||||||||||
| Full MetS | ≥ 3 MetS components | ||||||||||||
The data at baseline were used to define the 90th percentile of waist circumference and blood pressure. Definition of Pediatric MetS based on Cook et al. (
Characteristics of study participants at the time of recruitment.
| All (2,677) | Boys (1,059) | Girls (1,618) | |
|
| |||
| Primary | 1,650 (61.6) | 613 (57.9) | 1,037 (64.1) |
| Secondary | 1,027 (38.4) | 446 (42.1) | 581 (35.9) |
|
| |||
| Normal | 1,667 (62.3) | 591 (55.8) | 1,076 (66.5) |
| Overweight | 526 (19.6) | 204 (19.3) | 322 (19.9) |
| Obese | 484 (18.1) | 264 (24.9) | 220 (13.6) |
|
| |||
| Age (years) | 14.76 ± 1.7 | 14.89 ± 1.6 | 14.68 ± 1.7 |
| Weight (Kg) | 57.25 ± 18.6 | 61.89 ± 21.9 | 54.22 ± 15.4 |
| Height (cm) | 156.38 ± 10.7 | 159.45 ± 11.3 | 154.37 ± 9.8 |
| BMI (Kgm–2) | 23.34 ± 7.2 | 24.1 ± 7.6 | 22.85 ± 6.9 |
| Waist (cm) | 73.59 ± 17 | 74.62 ± 23 | 72.92 ± 11.6 |
| Hips (cm) | 89.00 ± 18.9 | 84.38 ± 25 | 92.01 ± 12.5 |
| Systolic BP (mm HG) | 118.6 ± 16.9 | 119.45 ± 14.8 | 118.04 ± 18.1 |
| Diastolic BP (mm HG) | 72.35 ± 12.5 | 67.8 ± 10.2 | 75.33 ± 13 |
|
| |||
| Cholesterol (mmol/l) | 4.4 ± 0.8 | 4.33 ± 0.8 | 4.45 ± 0.8 |
| HDL-Chol (mmol/l) | 0.99 ± 0.2 | 1.00 ± 0.2 | 0.98 ± 0.2 |
| Triglycerides (mmol/l) | 0.96 (0.8,1.3) | 1.03 (0.8,1.4) | 0.93 (0.8,1.2) |
| FBG (mmol/l) | 5.23 ± 1.2 | 5.31 ± 1.1 | 5.17 ± 1.2 |
| HbA1c | 5.10 ± 0.7 | 5.25 ± 0.7 | 5.00 ± 0.7 |
| 25 (OH) D (nmol/l) | 29.8 (22.2,39.4) | 36.1 (29,45.8) | 25.6 (20,34) |
|
| |||
| Central Obesity | 286 (10.7) | 111 (10.5) | 175 (10.8) |
| Hypertension | 602 (22.5) | 213 (20.1) | 389 (24.0) |
| Hypertriglyceridemia | 625 (23.3) | 298 (28.1) | 327 (20.2) |
| Low HDL_Cholesterol | 1,652 (61.7) | 598 (56.5) | 1,054 (65.1) |
| Hyperglycemia | 170 (6.4) | 81 (7.6) | 89 (5.5) |
| Full MetS | 256 (9.6) | 117 (11.0) | 139 (8.6) |
| MetS Components (N) | 1.25 ± 0.9 | 1.23 ± 1.1 | 1.26 ± 0.9 |
Data for categorical variables are presented as frequency (%) while for continuous variables are presented either as mean ± standard deviation or as median (quartile 1, quartile 3); *Based on the definition of Cole et al. (
Change in anthropometry and biochemical characteristics for those who completed the lifestyle change educational program.
| All (704) | Boys (331) | Girls (373) | |||||||
| Baseline | Follow-up | Baseline | Follow-up | ||||||
|
| |||||||||
| Overweight or Obese | 261 (37.1) | 238 (33.8) | 0.07 | 151 (45.6) | 141 (42.6) | 0.453 | 110 (29.5) | 97 (26.0) | 0.287 |
|
| |||||||||
| Age (years) | 14.91 ± 1.7 | 14.81 ± 1.6 | 14.99 ± 1.8 | ||||||
| Weight (kg) | 57.97 ± 20.1 | 59.85 ± 17.9 | < 0.001 | 62.87 ± 23.8 | 64.86 ± 21.2 | < 0.001 | 53.62 ± 14.8 | 55.4 ± 12.8 | < 0.001 |
| Height (cm) | 156.62 ± 1.3 | 160.52 ± 11.3 | < 0.001 | 159.45 ± 11.3 | 162.56 ± 11.9 | < 0.001 | 154.71 ± 10.2 | 158.72 ± 10.9 | < 0.001 |
| BMI (kg/m2) | 23.54 ± 7.8 | 23.25 ± 6.7 | 0.017 | 24.61 ± 8.2 | 24.38 ± 7.1 | 0.131 | 22.59 ± 7.3 | 22.25 ± 6.3 | 0.066 |
| Waist (cm) | 75.54 ± 16.2 | 77 ± 14.9 | 0.006 | 79.82 ± 19.7 | 86.2 ± 13.3 | < 0.001 | 71.75 ± 11 | 68.83 ± 11.1 | < 0.001 |
| Hips (cm) | 90.14 ± 17.4 | 85.25 ± 15.7 | < 0.001 | 89.14 ± 21.5 | 91.47 ± 14.4 | 0.009 | 91.03 ± 12.8 | 79.74 ± 14.8 | < 0.001 |
| Systolic BP (mm HG) | 119.78 ± 16.3 | 111.18 ± 13.6 | < 0.001 | 119.47 ± 14.8 | 117.63 ± 9 | 0.034 | 120.06 ± 17.5 | 105.45 ± 14.3 | < 0.001 |
| Diastolic BP (mm HG) | 71.98 ± 11.9 | 72.71 ± 8.4 | 0.161 | 67.76 ± 9.5 | 73.17 ± 9.7 | < 0.001 | 75.72 ± 12.5 | 72.3 ± 7 | < 0.001 |
|
| |||||||||
| Cholesterol (mmol/l) | 4.44 ± 0.8 | 6.23 ± 1.6 | < 0.001 | 4.4 ± 0.8 | 6.01 ± 1.4 | < 0.001 | 4.48 ± 0.8 | 6.42 ± 1.7 | < 0.001 |
| HDL-Chol (mmol/l) | 0.99 ± 0.2 | 1.57 ± 0.6 | < 0.001 | 1.01 ± 0.2 | 1.35 ± 0.5 | < 0.001 | 0.97 ± 0.2 | 1.76 ± 0.7 | < 0.001 |
| Triglycerides (mmol/l) | 0.95 (0.8,1.3) | 1.53 (1.1,2.1) | < 0.001 | 1.03 (0.8,1.3) | 1.63 (1.1,2.2) | < 0.001 | 0.91 (0.7,1.1) | 1.46 (1,1.9) | < 0.001 |
| FBG (mmol/l) | 5.24 ± 0.9 | 5.66 ± 2.8 | < 0.001 | 5.33 ± 1.2 | 5.79 ± 2.6 | 0.005 | 5.16 ± 0.7 | 5.54 ± 2.9 | 0.01 |
| HbA1c | 5.11 ± 0.6 | 5.32 ± 1.3 | < 0.001 | 5.23 ± 0.6 | 5.24 ± 1.2 | 0.679 | 5.00 ± 0.6 | 5.38 ± 1.3 | < 0.001 |
| 25 (OH) D (nmol/l) | 30.7 (22.9,39.5) | 38.7 (25.1,58.5) | < 0.001 | 35.6 (28.8,46.2) | 34.6 (24.4,49.5) | 0.253 | 25.7 (19.8,34) | 41.55 (25.6,63.1) | < 0.001 |
Data for categorical variables are presented as frequency (%) while for continuous scalar variables are presented either as mean ± standard deviation or as median (quartile 1, quartile 3). Relevant statistical tests were employed to check the differences pre- and post-intervention. p < 0.05 was considered statistically significant. “BMI” is body mass index and “FBG” is fasting blood sugar.
Prevalence of MetS and its individual components in Saudi adolescent’s pre- and post-intervention.
| Overweight or Obese | Central Obesity | Hypertension | Hyper triglyceridemia | Low HDL-Cholesterol | Hyperglycemia | Full MetS | MetS Components ( | |
|
| ||||||||
| Baseline | 261 (37.1) | 79 (11.2) | 157 (22.3) | 167 (22.7) | 434 (61.6) | 53 (7.5) | 67 (9.5) | 1.26 ± 0.9 |
| Follow-up | 238 (33.8) | 47 (6.7) | 80 (11.4) | 396 (56.3) | 164 (23.3) | 139 (19.7) | 55 (7.8) | 1.12 ± 0.9 |
| Change | 3.3 | 4.5 | 10.9 | 33.6 | 38.3 | 12.2 | 1.7 | 0.14 |
|
| 0.07 | 0.002 | < 0.001 | <0.001 | < 0.001 | <0.001 | 0.238 | 0.002 |
|
| ||||||||
| Baseline | 151 (45.6) | 48 (14.5) | 64 (19.3) | 95 (28.7) | 179 (54.1) | 28 (8.5) | 39 (11.8) | 1.25 ± 1.1 |
| Follow-up | 141 (42.6) | 28 (8.5) | 61 (18.4) | 199 (60.1) | 106 (32) | 69 (20.8) | 45 (13.6) | 1.32 ± 0.9 |
| Change | 3.0 | 6.0 | 0.9 | 31.4 | 22.1 | 12.3 | 1.8 | 0.07 |
|
| 0.453 | 0.015 | 0.769 | < 0.001 | <0.001 | < 0.001 | 0.487 | 0.337 |
|
| ||||||||
| Baseline | 110 (29.5) | 31 (8.3) | 93 (24.9) | 72 (19.3) | 255 (68.4) | 25 (6.7) | 28 (7.5) | 1.28 ± 0.9 |
| Follow-up | 97 (26.0) | 19 (5.1) | 19 (5.1) | 197 (52.8) | 58 (15.5) | 70 (18.8) | 21 (5.6) | 0.93 ± 0.8 |
| Change | 3.5 | 3.2 | 19.8 | 33.5 | 52.9 | 12.1 | 1.9 | 0.35 |
|
| 0.287 | 0.08 | < 0.001 | <0.001 | < 0.001 | <0.001 | 0.301 | < 0.001 |
Data are presented as frequency (%). Relevant statistical tests were employed to check the differences in the prevalence pre- and post-intervention.
Age-adjusted odds of the positive change in status of MetS and its components post intervention in participants with “overweight/obese” compared to the normal.
| MetS_components | Baseline | Follow-up | All (704) | Overweight/obese (B) (261) | Normal weight (B) (443) | Normal weight (B) | Overweight/obese (B) | |||
| O.R. (95% C.I.) |
| O.R. (95% C.I.) |
| |||||||
| Central Obesity | Yes | No | 43 (6.1) | 43 (16.5) | 0 (0.0) | Ref. | - | - | - | - |
| Hypertension | Yes | No | 128 (18.2) | 68 (26.1) | 60 (13.5) | Ref. | 2.25 (1.5–3.3) | < 0.01 | 2.28 (1.5–3.4) | < 0.01 |
| Hypertriglyceridemia | Yes | No | 58 (8.2) | 28 (10.7) | 30 (6.8) | Ref. | 1.65 (1.0–2.8) | 0.07 | 1.70 (1.0–2.9) | 0.06 |
| Low HDL-Cholesterol | Yes | No | 317 (45) | 131 (50.2) | 186 (42.0) | Ref. | 1.39 (1.0–1.9) | 0.035 | 1.36 (1.0–1.9) | 0.04 |
| Hyperglycemia | Yes | No | 41 (5.8) | 19 (7.3) | 22 (5.0) | Ref. | 1.50 (0.8–2.8) | 0.21 | 1.48 (0.8–2.8) | 0.23 |
| Subjects where status of at least one MetS components improved | 426 (60.5) | 187 (71.6) | 239 (53.9) | Ref. | 2.16 (1.6–3.0) | < 0.01 | 2.14 (1.5–3.0) | < 0.01 | ||
| Full MetS | Yes | No | 60 (8.5) | 44 (16.9) | 16 (3.6) | Ref. | 5.41 (2.9–9.8) | < 0.01 | 3.42 (1.8–6.5) | < 0.01 |
Data presented as frequency (%) represents the proportions of individuals where status changed from “yes” to “no” post intervention. Bivariate regression analysis was carried out to check the odds of these proportions in “overweight/obese at baseline” compared to “normal weight at baseline.” Superscripts “a” and “b” represents, respectively, “adjusted with age” and “adjusted with age and central obesity component.” p < 0.05 was considered statistically significant.
FIGURE 2A bar graph showing the percentages of positive change (from “yes” at baseline to “no” post-intervention) and negative change (from “no” at baseline to “yes” post-intervention) in MetS and its components. Here, comp. 1, 2, 3, 4, and 5 represent “central obesity,” “hypertension,” “low-HDL cholesterol,” “hypertriglyceridemia,” and “hyperglycemia,” respectively.